The regulation roles of Long Non-Coding RNA in the Chemoresistance Process of Ovarian cancer.

CONCLUSIONS: With the development of the study on drug resistance of ovarian cancer, the role of LncRNAs as sensitive biomarker and therapeutic target has emerged. And provides a direction for precision medicine of ovarian cancer resistance. PMID: 30947657 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30947657?dopt=Abstract

Source: Current Pharmaceutical Design - April 3, 2019 Category: Drugs & Pharmacology Authors: Qu J, Kamal MA, Yuan C Tags: Curr Pharm Des Source Type: research